diphenyleneiodonium has been researched along with Multiple Myeloma in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Adachi, M | 1 |
| Kawamura, R | 1 |
| Sakamoto, H | 1 |
| Hayashi, T | 1 |
| Ishida, T | 1 |
| Imai, K | 1 |
| Shinomura, Y | 1 |
1 other study available for diphenyleneiodonium and Multiple Myeloma
| Article | Year |
|---|---|
Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity.
Topics: Acetylcysteine; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; | 2006 |